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Abstract 
Background: VADs are relatively new developments in the management of advanced heart 
failure. In the UK, VAD recipients comprise a unique group of less than 200 patients. This is 
the first paper to explore the experience of VAD communities, the extent to which 
communities are developed around the device, and how these influence the experience of 
living with the VAD.  
Methods: Qualitative interviews were conducted with 20 VAD recipients (implanted as 
bridge to transplantation), 11 interviews also included the VAD recipients’ partners. 
Interpretive phenomenology was employed as the theoretical basis guiding the analysis of the 
interviews.  
 Results: Four key themes emerged from the data: the existence of VAD communities; 
experiential knowledge and understanding; social comparisons; and the impacts of deaths 
within the VAD community. Many of the interviewees valued the VAD communities and the 
relationships they had formed with fellow recipients. Beneficial impacts of the VAD 
communities included offering recently implanted patients a realistic view of what to expect 
from life with a VAD, this could aid them in accepting and adapting to the changes imparted 
by the device.  However, negative impacts of the VAD communities were also reported, in 
particular following deaths within the group which were a source of distress for many of the 
interviewees. 
Conclusions: In general, the VAD communities appeared to be a beneficial source of support 
for the majority of interviewees.  Consideration should be given to how these communities 
could be supported by clinicians.  
Keywords: Ventricular Assist Devices; Bridge to Transplantation; Heart Failure; Patient 
Communities; United Kingdom 
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Introduction 
Ventricular Assist Devices (VADs) are a form of mechanical circulatory support that are 
being used increasingly in the management of advanced heart failure. VADs augment, or 
fully take over, the pumping function of an individual’s heart. There are two distinct types of 
VAD, transcutaneous and implantable;1 this paper focuses specifically on implantable 
devices.  VADs comprise of internal and external components; the external components 
include the controller and power source. The controller manages the flow of the pump, and 
communicates information about how the device is working, it has the capacity to produce 
textual alerts and alarms.2 The VAD must be connected to a power source at all times either 
through specialised battery packs or mains electricity.  
Implantation of the VAD involves major open heart surgery and a lengthy rehabilitation 
period, however the devices are designed to allow recipients to live at home.3 Day-to-day 
management of the device places substantial demands on the recipient4 including: 
maintaining power supply, cleaning and dressing the exit wound, and managing medications. 
The VAD also carries substantial risks including: bleeding and thrombosis, stroke, infection, 
and device malfunction.5 It has been suggested that the realities of living with the device may 
not be fully appreciated until they are personally experienced.6 The VAD can be a source of 
fear and anxiety7, 8, it can lead recipients to experience a loss of independence7-10,  and 
distress about the uncertainty of their situation.11  
In the US and Canada there are over 15,000 people living with VADs.12 However, in the UK 
use of these devices is still in its infancy and VAD recipients form a rare patient group. 
Whilst there are over half a million people living with heart failure in the UK,13 there are less 
than 200 individuals currently on VAD support, and only around 600 devices have been 
implanted since 2004.14 These disparities are partly due to commissioning limitations in the 
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UK which only allow for the devices to be used as a bridge to transplantation (BTT) or for 
myocardial recovery.15 In the US, and much of mainland Europe, VADs are also used as a 
destination therapy (DT) which is an alternative to transplantation. DT accounts for up 40% 
of individuals fitted with VADs in the US.16  
Although, VAD recipients in the UK comprise a small group, they may encounter each other 
at several points: prior to implantation at meetings arranged by clinicians, during inpatient 
stays at the hospital, and at clinic appointments. All of these meeting points are potential 
starting points for new long-term relationships. However, there is currently limited research 
exploring the social networks of VAD recipients, and what does exist has focused almost 
solely on the impacts on caregivers.7, 17-22 To our understanding this is the first paper to 
explore the experience of communities developed around VADs, the extent to which these 
communities exist and their influence on the experience of living with the device.  
Methods 
Study design 
This explorative qualitative study used interviews with patients who were living with, or had 
lived with a VAD. This paper focuses on one aspect of a study conducted as part of a PhD.23  
The study was conducted under the principles of the Declaration of Helsinki24 and was 
approved by a NHS Research Ethics (Committee Reference: 12/NE/0218).  
Sampling and recruitment 
Clinician gatekeepers, specialist nurses and cardiologists, were used throughout the study to 
gain access to the study sample. Individuals were invited to participate in the study if they 
were living with, or had previously lived with a VAD. Clinician gatekeepers made the first 
approach about the study, they provided potential participants with the information sheet and 
sought consent for the researcher to make contact. Interested participants were then contacted 
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by the researcher to set up the interview. Figure 1 shows the recruitment procedure. 
Participants were given the option of participating in the interview alone, having a partner 
present, or having someone participate in the study on their behalf to give a proxy account of 
their experience, however no one chose to take up this latter option.  
Figure 1 here 
A combination of purposive sampling25 approaches were  employed to ensure the study gave 
as full an account of the experience of living with a VAD as possible. The first round of data 
collection employed typical case sampling, clinicians were asked to identify individuals 
whom they considered to be ‘typical’ VAD recipients.  As the study progressed, critical case 
sampling was used to identify individuals with specific characteristics that might test themes 
emerging from the data.  For example, both those who were highly sociable within the VAD 
group, and those who sought to avoid contact with other VAD recipients were sampled. Data 
collection ceased when no new themes were emerging from the data. Ten VAD recipients 
approached by clinician gatekeepers declined to participate or withdrew before the interview 
was conducted. All respondents provided written informed consent for participation in the 
study.  
Interviews were initiated with the question ‘please tell me a bit about the process by which 
you came to receive a VAD?’ This approach was intended to elicit a brief synopsis of the 
individual’s medical history, allowing respondents the opportunity to give the history of their 
illness in their own words. An interview guide was developed for the interviews covering the 
following broad areas: experience leading up to and following implantation of the VAD; 
management of the physical components of the VAD; impact of the VAD on identity; and 
hopes and expectations for the future. All participants were asked about these broad areas. 
The interview guide was not a fixed document, it evolved over the course of the study in 
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response to themes emerging from the interviews.  In line with the phenomenological 
approach the interviewer was open to topics and issues raised by individual participants.26 For 
example, the idea of VAD communities emerged from the interviews themselves, this was 
not an issue that had been anticipated in advance, but was explored in greater depth through 
subsequent interviews.   
Interviews were tape recorded and transcribed verbatim by the first author. 
Qualitative analysis 
Data analysis was informed by Heidegger’s interpretive phenomenology.27 The first step of 
data analysis involved familiarisation with the data through transcription of the interviews, 
and close reading. The second stage of analysis was to turn to each transcript individually, 
using line-by-line and highlighting approaches. 28 Transcripts were initially analysed line-by-
line, this involved close reading whilst attributing a code to each segment of text, as the 
analysis went on there was a tendency to adopt a highlighting approach.  Data collection and 
analysis occurred concurrently, emerging themes informed the interview guide for 
subsequent interviews and early transcripts were re-examined in light of subsequent 
interviews.  
Trustworthiness of the data was ensured by several means including discussion of emerging 
themes within the study team, and detailed discussions of individual transcripts with a peer 
network of qualitative researchers. Whilst we did not engage in member checking 29   
emerging themes were discussed in subsequent interviews. Findings were also fed back to 
key clinicians who acted as gatekeepers for the study. The purpose of this step was to 
establish whether the findings of the study were consistent with the clinicians’ own 
experiences of working with this group. However, we acknowledge that the clinicians only 
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have access to the VAD recipients in the clinical setting, so their observations are limited to 
this environment.  
Results 
Overview 
Twenty VAD recipients were interviewed, in eleven of the interviews a partner was also 
present and included in the interview. There did not appear to be a pattern in terms of who 
opted to have a partner present. Where the patient was married or in a long term relationship 
the partner was present in 10 of the 17 interviews. All of the respondents who were single 
participated in the interview alone. Participants of both genders included their partners in the 
interviews, and partners were included in interviews of participants across all of the age 
brackets.  Interviews lasted between 40 to 105 minutes. All interviews were conducted face-
to-face. The majority of interviewees were living with a HeartWare® II device, all were 
implanted at the same centre under the indication of BTT. Table 1 outlines demographic 
factors of the participants in further detail.  
Table 1 here. 
Four key themes emerged from the data: existence of VAD communities, experiential 
knowledge and understanding, social comparisons and impact of deaths within the patient 
group. Table 2 provides quotations for themes and subthemes. All names are pseudonyms. 
Table 2 here 
Existence of VAD communities 
It was apparent that communities existed between many of the VAD recipients interviewed. 
Interviewees indicated they often utilised hospital appointments as an opportunity to socialise 
with other VAD recipients.  
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If you come to the clinic we all sit together or if there’s any ‘dos’[social 
events] all the VAD people stand together. (Gary) 
For the majority of interviewees, the shared device was a link that drew them together with 
other recipients. Respondents were not necessarily all part of the same group, or community, 
but it was evident that most had formed relationships with other VAD recipients.  In the 
majority of cases, these relationships were maintained outside of the hospital through text 
messages, telephone calls, and meet-ups.  
Two of our closest friends at the moment are Connor and Helen (VAD 
recipient and wife) … they sort of text or phone once a week, once every 
couple of weeks and we can just unload on them. (Fred) 
VAD recipients and their partners had often developed relationships with other couples with 
whom they met up on a regular basis. However, younger VAD recipients, and those not in 
relationships also spoke of friendships they had with other recipients. 
I went to the rehab groups for about a year or so just to get back in exercise 
and stuff like that I was the youngest one by about 40 years when I went, 
me and all the old dears it was great, I used to get a fuss made of us every 
time … I met like 4 or 5 other people who had VADs and got really good 
mates with them. (Grant) 
However, some of the interviewees expressed no desire to socialise with other recipients, 
indicating they saw no value in these contacts.  
...if I’d broke my leg and somebody else broke their leg, does that mean 
we’ve got anything else other than that in common. (Albert) 
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Albert rejected the notion that the VAD was a sufficient basis for a sense of community; 
neither the VAD nor heart failure appeared integral to his sense of identity, and he did not 
wish to be defined through them. 
Experiential knowledge and understanding 
Although many of the interviewees had long histories of heart failure, the VAD was a new 
and potentially intimidating approach to managing their condition, of which they had little to 
no experience. Many had never heard of VADs prior to receiving one and the newness of the 
device to them could leave recipients feeling frightened and isolated. Contact with another 
VAD recipient could be an important transition point where they stopped feeling alone and 
began to feel part of a community.  
I went from feeling as if I was on my own to then, well actually there’s 
quite a few people (Fran) 
Fellow VAD recipients were seen as a valued source of support. Contact with other VAD 
recipients appeared to be particularly beneficial around implantation, offering an insight into 
the realities of life with the device. Fellow VAD recipients offered the interviewees 
something that was missing from their other relationships, true insight and understanding of 
life with the device. 
I found it a lot better talking to someone whose actually been there and 
done that, who’s actually gone through the experience themselves. (Jack) 
Exposure to fellow VAD recipients offering positive accounts of life with the device could 
alleviate fears, offering those who are living with uncertainty the hope of a more favourable 
future. However, some interviewees had also encountered those with negative accounts, 
which could have a potentially harmful impact.  
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There was a negative gentleman on the ward and you just wanted to say 
‘shut up, we don’t want to hear it’ (Hannah, wife of Paul) 
 
The VAD communities also offered recipients the opportunity to share tips regarding the day-
to-day management of the VAD.  
Some people are very knowledgeable about them [VADs], very helpful, and 
it’s really practical stuff, you know, that they can be very helpful with. 
(James) 
Sharing advice on practical management of the device could spare recent VAD recipients 
some of the time-consuming and frustrating work of trying to fit the device into their day-to-
day lives.  
Adopting the role of ‘experienced patient’ by meeting prospective VAD recipients, could also 
have positive impacts for the individual. 
It helps me as well … it actually helps me to understand what I was going 
through as well. (Jack)  
Using personal experiences to reassure others and being positioned as someone who can 
(genuinely) help may allow recipients to develop new, and valued, identities that may replace 
those lost by the implantation of the device.   
Social comparisons 
Meeting other VAD recipients may also offer an opportunity for recipients to determine how 
well they are comparatively coping with the device. The majority of interviewees appeared to 
choose to compare themselves against VAD recipients who had experienced a number of 
problems with the device. 
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We [Fred and his wife] don’t spend much time in hospital compared with 
other people on VADs. (Fred) 
Reflecting that others’ situations are worse may allow individuals to feel fortunate within a 
context, facilitating a positive view of their situation. These comparisons were not limited to 
health status, but could focus on other aspects of life with the VAD. For example, relative 
proximity to the hospital could alleviate concerns about the responsibility of managing the 
VAD, due to the security offered by having expert support close to hand.  
Interestingly, the majority of interviewees positioned their experience as comparing 
favourably to other recipients.   
Everybody I talked to they’ve all had infections, they’ve all had clots, water 
retention, [and] stuff like that. Some’ve had the VAD changed. (Matt) 
Matt had actually experienced numerous complications with the VAD, including several 
driveline infections, and it is unlikely that every fellow recipient he encountered had fared 
worse. However, his focus on the negative experiences of others may be a stratagem for 
remaining positive about his own situation.  
Not all of the respondents felt that comparing themselves to other VAD recipients was useful.  
The way I look at it, everybody’s different, nobody’s the same. So you 
know, what happens to one patient probably, definitely wouldn’t happen to 
another, you know there’s not one patient the same. (Ian)  
Rather than comparing himself to others, Ian stressed that everybody is different; 
comparisons are futile and will not provide any useful information about his own potential 
outcomes.  
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Impact of deaths within the VAD community 
Death of a fellow VAD recipient appeared to have far-reaching impacts on many of those in 
the VAD community.  
I’ve actually had, unfortunately, two people who’ve died, one of my friends 
Andy … what I found hardest, because I’d met his family, I’d met his 
daughter and his two granddaughters and he’d waited so long for a 
transplant but then he died a couple of days later … losing those two people 
was a bit hard to deal with. (Jack) 
Death of a fellow VAD recipient appeared to have the greatest impact when there was a 
shared characteristic or other link. As Jack indicates above, Andy was not just a casual 
acquaintance there was a ‘deeper’ level of friendship.  
A death amongst the VAD group often precipitated concerns of suffering the same fate.  
It makes you start analysing yourself. You start analysing what’s happened 
to them, what did they do compared to what you do? … what kind of 
lifestyle did they have compared to what you do?  (Ned) 
Several of the interviewees reported trying to seek out as much information as possible about 
why other recipients had died. In particular, they wanted to ascertain whether the individual 
was at fault or whether there had been a problem with the device. A ‘fault’ with the 
individual appeared to be preferable as this affords the VAD recipients some control over 
their fate. Information gathered about the misfortune of others could be used to inform their 
own care regimens, however there is little they could do to safeguard themselves against a 
fault with the device.  
Death of fellow VAD recipients could also result in feelings of frustration and anger towards 
the clinical team.  
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One of the lads I met on [the ward], just before Christmas … he seemed 
alright, he was dead chatty and next minute … she come in (his wife) and 
he didn’t recognise her … and then he died two days later … I thought 
‘bloody hell, it can happen that quick’ … It just seems that a lot of people 
are now having more problems with it but obviously it’s new and it’s all to 
do with infection. (Stephan) 
Witnessing such a dramatic shift in the condition of another could bring the fragility of their 
own condition, and mortality, into stark relief. Stephan’s account also suggests a degree of 
irritation with the clinical team and an implication that he did not feel sufficiently prepared 
for the likelihood of experiencing such problems.   
Discussion 
This is the first paper to explore the experience of VAD communities, the extent to which 
they are developed around the device, and the influence on the experience of living with the 
device. Previous research has indicated that the opportunity to meet other VAD recipients and 
caregivers is an important event in the decision-making process,30, 31 and a high value is 
placed on the information gained from other recipients.4 The findings of this study indicate 
that whilst not all VAD recipients subscribe to the idea of a VAD community, the majority of 
interviewees find these relationships extremely beneficial. The value and significance of 
these relationships may change over time; they may be particularly valuable leading up to and 
immediately following implantation. Friendship with other recipients who are successfully 
living with the VAD appears to reduce feelings of isolation as well as allaying fears and 
fostering hope of a positive outcome. Similar impacts have been found amongst cancer 
patients 32 as well as for online support groups.33 
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VAD communities also appear to be a useful resource for learning how to cope with the 
device. Fellow VAD recipients are the only ones who possess experiential knowledge of life 
with the device. Experiential knowledge is defined as knowledge gleaned through personal 
experience with a phenomenon.34 Research exploring the experience of living with a stigma 
has suggested that contact with others who share a stigma can be a source of practical and 
social support, through which the ‘tricks of the trade’ may be learnt.35  Further, shared 
experiential knowledge can facilitate the development of a communal body of knowledge 
known as ‘experiential expertise’ that exceeds the boundaries of individual experience.36 
Indeed, interviewees described sharing tips for living with the device. The VAD communities 
appear to offer recipients an understanding of the experience of living with the device that is 
lacking from relationships with family and friends.  
The VAD communities also allowed recipients to make social comparisons. Social 
comparisons occur between those who are similar or experiencing similar problems.37 They 
are particularly prevalent in situations of fear and uncertainty,37 where the preference is often 
for evaluation against less fortunate others38 allowing for a more positive view of one’s own 
situation.39 Many of the VAD recipients made downward comparisons to position themselves 
as more fortunate. However, as has been noted amongst patients with motor neuron disease, 
40 the benefits of the VAD communities went beyond those which can be explained be social 
comparison theory to include exchange of practical advice and information, a sense of 
camaraderie and the potential to help others.  
Potentially negative impacts of the VAD community were evident in the form of the distress 
experienced following a death within the group. Previous research suggests that death of a 
group member is one of the most difficult challenges faced by cancer support groups.32  
Amongst hospice patients, it is suggested that awareness of the death of a resident leads 
others to reflect on their own future.41 Indeed, deaths appear to be a major event amongst 
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VAD recipients leading to grief at the loss of a friend as well as sparking fear of suffering the 
same fate. However, awareness of the death of fellow VAD patients may also act as a 
reminder of the vulnerability of their condition and a useful motivation to ensure they remain 
vigilant about the management of their device, in order to avoid experiencing similar 
outcomes themselves.   
This paper is the first to discuss the impact of deaths within the VAD group. However, this is 
an under explored area in general, there is little previous literature exploring responses to 
deaths within patient communities. The majority of literature that does exist focuses on 
hospice patients, which has limited application to the VAD group. Deaths amongst hospice 
patients are often reported as more comforting than distressing.42 43 There is an assumption 
that hospice patients are nearing the end-of-life; death is expected, this not necessarily the 
case for VAD recipients. In UK context where VADs are primarily used as a BTT, rather 
than DT, witnessing others deteriorating, and dying, with the device is likely lead to upset 
and concerns over one’s own future. However as the number of individuals fitted with VADs 
increases, deaths within this group will become increasingly common. As such, it is 
important to consider how to manage the impact on the wider VAD group. 
The majority of interviewees appeared to have some degree of relationship with other VAD 
recipients. One of the influences on the degree of these relationships appeared to be 
geographical proximity to the implanting centre, and/or other VAD recipients. There was a 
group of recipients whom lived close to the implanting centre whom had become close 
friends whilst living with the device, and met up regularly. This group was relatively mixed 
in terms of the recipients ages, ranging from those in their 20s to late 50s, recipients sex, and 
relationship status. Other interviewees described close relationships with fellow recipients 
whom lived near-by. Given that the implanting centre from which we recruited covered a 
wide geographical area, it is likely that some individuals implanted with a VAD will not live 
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in close proximity to another recipient. This may have implications for the level of support 
that these patients require, it may be beneficial to monitor those who are live further away 
from the implanting centre, and other recipients, to ensure that they do not become isolated.  
Limitations 
Participants were sampled from a single VAD implanting centre, one of the largest in the UK; 
the experiences reported may have limited transferability outside of this context. Although 
the implanting centre where this study was conducted covered a wide geographical area, and 
attempts were made to sample a diverse range of participants, with different experiences’ of 
living with the device, our participants were relatively homogenous, for example all were 
white British or Irish. Further research around VAD communities in the UK would benefit 
from a comparison between different implanting centres to test whether similar findings are 
evident amongst more diverse VAD populations. Further, given the differences in the 
commissioning of VADs between the UK and other countries, findings may not be 
transferable to countries where the devices are more commonly used.  
Participants were sampled via clinician gatekeepers. Although efforts were made to ensure 
that a range of VAD recipients were included, gatekeepers had ultimate control over who was 
approached regarding participation meaning there may have been some patients’ accounts 
which we do not have access to as clinicians decided not to approach them about 
participation in the study. Further research would benefit from using a range of recruitment 
methods, including those that would allow interested participants to approach the researcher 
without going through clinician gatekeepers.  
As mentioned previously, at the implanting centre where this study was conducted there was 
a group of VAD recipients who had formed a particularly close friendship group. Several 
members of this group were interviewed, and it was evident they had discussed their 
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participation with each other. Their accounts, whilst useful, provide a very specific reflection 
on life with the device and are unlikely to be transferable to individuals outside of this group. 
Through purposive sampling approaches we sought to include those who had low 
engagement with other VAD recipients, however it is likely that those who were most 
isolated also chose not to participate in the study. 
This paper does not discuss the role of internet support groups and forums.  Only one 
respondent mentioned contributing to an American online forum for VAD recipients, 
although others reported watching YouTube videos of the implantation operation. It was 
decided that there was not sufficient data to discuss implications of online forums so this 
paper refrains from making inferences about this form of social exchange. A recent survey 
study has highlighted the potential of social media as a platform both for fostering virtual 
communities amongst VAD patients and disseminating evidence based practices for self-
care.44 Further research is required to explore the potential utility of these platforms.   
In this paper we focus primarily on the community of VAD recipients themselves, however, 
it was apparent throughout the interviews that communities also existed around the partners/ 
caregivers of the VAD recipients. Previous literature has highlighted the major impact of 
caregiving for VAD recipients,18 indicating a need for long term professional support.45  It is 
likely that, as with the VAD recipients themselves, the development of communities around 
the VAD will be beneficial for relatives and caregivers. Future research should consider the 
development and impact of these networks.   
Allowing partners to be present, and participate in the interviews, was an intentional decision 
by the research team when designing the study. We felt that this would help ensure that 
respondents felt comfortable in the research process. Partners were present in 11 of the 
interviews conducted. As mentioned in the methods section of the paper, there did not appear 
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to be a pattern in terms of which participants chose to include partners in the interview, 
however there may have been some practical factors influencing the decision. Although 
participants were given a choice regarding the location of the interview, all opted for the 
interviews to be conducted at the implanting centre. Several of the participants were in-
patients at the hospital at the time of the interview, so options regarding location for the 
interview were limited, and the remainder of the interviewees opted to coincide the interview 
with their clinical appointments. For interviewees who were in-patients at the time of the 
interview, whether or not a partner was present may have been influenced by whether the 
interview coincided with visiting time on the ward.  
Conclusion 
Overall, contact with other VAD recipients appears to be beneficial to VAD recipients in 
helping them accept and learn to live with the device. Other VAD recipients were an 
important source of social support, offering experiential knowledge about life with the device 
and a level of understanding that may be missing from other social networks. Although, death 
of a VAD recipient could cause concerns within the group, this does not appear to outweigh 
the positive benefits of these communities but indicates a need for work to manage the impact 
of deaths within the patient group. 
19 
 
References 
1. National Heart L, and Blood Institute,. Ventricular Assist Device. 2016 (accessed  27 
April). https://www.nhlbi.nih.gov/health/health-topics/topics/vad 
2. HeartWare®. Managing the Equipment. 2017 (accessed  27th April). 
https://www.heartware.com/patients-caregivers/managing-equipment 
3. Neoh K, Holmes S, Woods A, et al. A Matter of Time: The Case of a Patient With a 
Left Ventricular Assist Device. Journal of Pain and Symptom Management. 2016; 52: 752-5. 
4. Ottenberg AL, Cook KE, Topazian RJ, et al. Choices for Patients “Without a Choice” 
Interviews With Patients Who Received a Left Ventricular Assist Device as Destination 
Therapy. Circulation: Cardiovascular Quality and Outcomes. 2014; 7: 368-73. 
5. Rogers JG. Managing VAD Complications. Journal of the American College of 
Cardiology. 2016; 67: 2769. 
6. Steiner J, Beckman, J., Cooper, S., Smith, J. W., Kirkpatrick, J. N., Mahr, C. Hope for 
the best, plan for the worst: integrating palliative care in mechanical circulatory support. 
ISHLT Links. 2016; 8. 
7. Kaan A, Young Q-R, Cockell S, et al. Emotional experiences of caregivers of patients 
with a ventricular assist device. Progress in Transplantation. 2010; 20: 142-7. 
8. Zambroski CH, Combs P, Cronin SN, et al. Edgar Allan Poe,“the pit and the 
pendulum,” and ventricular assist devices. Critical care nurse. 2009; 29: 29-39. 
9. Hallas C, Banner NR and Wray J. A qualitative study of the psychological experience 
of patients during and after mechanical cardiac support. Journal of Cardiovascular Nursing. 
2009; 24: 31-9. 
  20 
10. Casida JM, Marcuccilli L, Peters RM, et al. Lifestyle adjustments of adults with long-
term implantable left ventricular assist devices: a phenomenologic inquiry. Heart & Lung: 
The Journal of Acute and Critical Care. 2011; 40: 511-20. 
11. MacIver J and Ross HJ. Quality of life and left ventricular assist device support. 
Circulation. 2012; 126: 866-74. 
12. Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 
patients and counting. The Journal of Heart and Lung Transplantation. 2015; 34: 1495-504. 
13. British Heart Foundation. Heart Failure. 2017 (accessed  1 March 2017). 
https://www.bhf.org.uk/heart-health/conditions/heart-failure 
 
14. NHS Blood and Transplant. Annual report on ventricular assist devices. 2015 
(accessed). www.odt.nhs.uk/pdf/nhsbt_annual_vad_report.pdf  
 
15. NHS Commissioning Board. 2013/14 NHS standard contract for ventricular assist 
devices (VADs) as a bridge to heart transplantation or myocardial recovery. 2013 (accessed  
10th August). http://www.england.nhs.uk/wp-content/uploads/2013/06/a18-vad-all.pdf 
 
16. Kirklin JK, Naftel, D. C., Pagani, F. D., Kormos, R. L., Stevenson, L. W., Blume, E. 
D., Miller, M. A., Baldwin, J. T., and Young, J. B. Sixth INTERMACS annual report: A 
10,000-patient database’. The Journal of Heart and Lung Transplantation. 2014; 33: 555-64. 
17. Casida J. The lived experience of spouses of patients with a left ventricular assist 
device before heart transplantation. American Journal of Critical Care. 2005; 14: 145-51. 
  21 
18. Egerod I and Overgaard D. Taking a back seat: support and self-preservation in close 
relatives of patients with left ventricular assist device. European Journal of Cardiovascular 
Nursing. 2012; 11: 380-7. 
19. Kirkpatrick JN, Kellom K, Hull SC, et al. Caregivers and left ventricular assist 
devices as a destination, not a journey. Journal of cardiac failure. 2015; 21: 806-15. 
20. Kitko LA, Hupcey JE, Gilchrist JH, et al. Caring for a spouse with end-stage heart 
failure through implantation of a left ventricular assist device as destination therapy. Heart & 
Lung: The Journal of Acute and Critical Care. 2013; 42: 195-201. 
21. Magid M, Jones J, Allen LA, et al. The perceptions of important elements of 
caregiving for a left ventricular assist device patient: a qualitative meta-synthesis. Journal of 
Cardiovascular Nursing. 2016; 31: 215-25. 
22. Marcuccilli L and Casida JM. From insiders' perspectives: adjusting to caregiving for 
patients with left ventricular assist devices. Progress in Transplantation. 2011; 21: 137-43. 
23. Standing, H. 'Being' a Ventricular Assist Device Recipient: A Liminal Existence. 
2016. 
24. World Medical Association. Declaration of Helsinki: ethical principles for medical 
research involving human subjects. Jama. 2013; 310: 2191. 
25. Patton M. Qualitative evaluation and research methods. California: SAGE, 1990. 
26. Finlay L. A Dance Between the Reduction and Reflexivity: Explicating the" 
Phenomenological Psychological Attitude". Journal of Phenomenological Psychology. 2008; 
39: 1-32. 
27. Heidegger M. Being and Time. Oxford: Wiley-Blackwell, 1962. 
28. Van Manen M. " Doing" Phenomenological Research and Writing: An Introduction. 
1984. 
29. Lincoln YS, Guba , E. G. Naturalistic Inquiry. Newbury Park: SAGE, 1985. 
  22 
30. Blumenthal-Barby JS, Kostick KM, Delgado ED, et al. Assessment of patients’ and 
caregivers’ informational and decisional needs for left ventricular assist device placement: 
implications for informed consent and shared decision-making. The Journal of Heart and 
Lung Transplantation. 2015; 34: 1182-9. 
31. McIlvennan CK, Jones J, Allen LA, et al. Decision-Making for Destination Therapy 
Left Ventricular Assist Devices. Circulation: Cardiovascular Quality and Outcomes. 2015; 
8: 172-8. 
32. Ussher J, Kirsten L, Butow P, et al. What do cancer support groups provide which 
other supportive relationships do not? The experience of peer support groups for people with 
cancer. Social science & medicine. 2006; 62: 2565-76. 
33. Ziebland S and Wyke S. Health and illness in a connected world: how might sharing 
experiences on the internet affect people's health? Milbank Quarterly. 2012; 90: 219-49. 
34. Borkman T. Experiential knowledge: A new concept for the analysis of self-help 
groups. The Social Service Review. 1976: 445-56. 
35. Goffman E. Stigma: notes on the management of spoiled identity. London: Penguin, 
1963. 
36. Caron-Flinterman JF, Broerse JEW and Bunders JFG. The experiential knowledge of 
patients: a new resource for biomedical research? Social science & medicine. 2005; 60: 2575-
84. 
37. Festinger L. A theory of social comparison processes. Human relations. 1954; 7: 117-
40. 
38. Taylor SE and Lobel M. Social comparison activity under threat: downward 
evaluation and upward contacts. Psychological review. 1989; 96: 569. 
39. Wills TA. Downward comparison principles in social psychology. Psychological 
bulletin. 1981; 90: 245. 
  23 
40. Locock L and Brown JB. ‘All in the same boat’? Patient and carer attitudes to peer 
support and social comparison in Motor Neurone Disease (MND). Social science & medicine. 
2010; 71: 1498-505. 
41. Rivolta MM, Rivolta L, Garrino L, et al. Communication of the death of a patient in 
hospices and nursing homes: A qualitative study. European Journal of Oncology Nursing. 
2014; 18: 29-34. 
42. Honeybun J, Johnston M and Tookman A. The impact of a death on fellow hospice 
patients. British journal of medical psychology. 1992; 65: 67-72. 
43. Payne S, Hillier R, Langley-Evans A, et al. Impact of witnessing death on hospice 
patients. Social science & medicine. 1996; 43: 1785-94. 
44. Boling B, Hart A, Okoli CTC, et al. Use of Social Media as a Virtual Community and 
Support Group by Left Ventricular Assist Device (LVAD) Patients. The VAD Journal. 2015; 
1: 18. 
45. Akbarin M and Aarts C. Being a close relative of a patient with a left ventricular 
assist device. European Journal of Cardiovascular Nursing. 2012; 12: 64-8. 
  
 
 
 
